Passage Bio, Inc.
NASDAQ:PASG
0.596 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 21.709 | 34.601 | 128.965 | 135.002 | 158.874 | 24.861 |
| Short Term Investments
| 92.585 | 155.009 | 186.808 | 169.815 | 0 | 0 |
| Cash and Short Term Investments
| 114.294 | 189.61 | 315.773 | 304.817 | 158.874 | 24.861 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 3.665 | 0.926 | 1.726 | 12.366 | 6.901 | 8.538 |
| Total Current Assets
| 117.959 | 197.044 | 325.066 | 317.183 | 165.775 | 33.399 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 32.153 | 42.238 | 23.806 | 2.795 | 1.087 | 0.028 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.433 | 4.267 | 6.204 | 5.234 | 11.751 | 0.034 |
| Total Non-Current Assets
| 32.586 | 46.505 | 30.01 | 8.029 | 12.838 | 0.062 |
| Total Assets
| 150.545 | 243.549 | 355.076 | 328.007 | 178.613 | 33.461 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 1.298 | 4.065 | 9.448 | 5.265 | 0.629 | 0.212 |
| Short Term Debt
| 3.373 | 3.275 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 11.67 | 11.011 | 20.05 | 15.91 | 3.052 | 0.095 |
| Total Current Liabilities
| 16.341 | 18.351 | 29.498 | 21.175 | 3.681 | 0.307 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 22.921 | 23.832 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 6.921 | 2.118 | 0.58 | 45.327 |
| Total Non-Current Liabilities
| 22.921 | 23.832 | 6.921 | 2.118 | 0.58 | 45.327 |
| Total Liabilities
| 39.262 | 42.183 | 36.419 | 23.293 | 4.261 | 45.634 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 328.007 | 0.231 | 43.118 |
| Common Stock
| 0.005 | 0.005 | 0.005 | 0.004 | 0.003 | 0.002 |
| Retained Earnings
| -594.468 | -492.406 | -356.281 | -170.895 | -58.663 | -13.029 |
| Accumulated Other Comprehensive Income/Loss
| -0.043 | -0.966 | -0.413 | -0.012 | -0.231 | -0 |
| Other Total Stockholders Equity
| 705.789 | 694.733 | 675.346 | 147.61 | 233.012 | -42.264 |
| Total Shareholders Equity
| 111.283 | 201.366 | 318.657 | 304.714 | 174.352 | -12.173 |
| Total Equity
| 111.283 | 201.366 | 318.657 | 304.714 | 174.352 | -12.173 |
| Total Liabilities & Shareholders Equity
| 150.545 | 243.549 | 355.076 | 328.007 | 178.613 | 33.461 |